Resumption of growth after methionyl-free human growth hormone therapy in a patient with neutralizing antibodies to methionyl human growth hormone

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue 5, 2002, Pages 653-657

  Pitukcheewanont, Pisit ^a   Schwarzbach, Liz ^a   Kaufman, Francine Ratner ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

GH; GH antibodies; GH binding capacity; GH deficiency; Growth velocity; Neutralizing anti growth hormone (GH) antibodies; Recombinant methionyl human GH; Recombinant methionyl free human GH

Indexed keywords

GROWTH HORMONE ANTIBODY; HUMAN GROWTH HORMONE; NEUTRALIZING ANTIBODY; SOMATREM; ANTIBODY; DRUG DERIVATIVE;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BODY HEIGHT; CASE REPORT; CHILD GROWTH; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE BINDING; HUMAN; MALE; SCHOOL CHILD; SIDE EFFECT; AGING; BLOOD; IMMUNOLOGY; TREATMENT FAILURE;

ADOLESCENT; AGING; ANTIBODIES; BODY HEIGHT; HUMAN GROWTH HORMONE; HUMANS; MALE; TREATMENT FAILURE;

EID: 0036013254     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2002.15.5.653     Document Type: Article

References (16)

1. Current experience with Somatrem in Japan
2. Current clinical trials with authentic recombinant human growth hormone in Japan
3. Clinical experience with somatonorm
4. Treatment of pituitary dwarfism with biosynthetic growth hormone
5. Clinical studies with recombinant DNA-derived methionyl human growth hormone in growth hormone deficient children
6. A case report of growth attenuation during methionyl human growth hormone treatment
7. Experience of treatment with pituitary derived human growth hormone with special reference to immunological aspects
8. Acquired resistance to human growth hormone caused by specific antibodies
9. Growth hormone antibodies in patients treated with different preparations of human growth hormone (hGH)
10. Restoration of growth by human growth hormone (Roos) in hypopituitary dwarfs immunized by other human growth hormone preparations: Clinical and immunological studies
11. High incidence of anti-GH antibodies in subjects treated with the GH clinical preparation available in Italy
12. Development of anti-hGH antibodies during therapy with authentic human growth hormone
13. Growth hormone blocking antibodies in a patient with the GH-N gene
14. Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA
15. Safety of recombination deoxyribonucleic acid-derived growth hormone: The National Growth Study Experience
16. Growth stop in a GH deficient patient, under treatment with rhGH